MICHAEL LEWIS to Erlotinib Hydrochloride
This is a "connection" page, showing publications MICHAEL LEWIS has written about Erlotinib Hydrochloride.
Connection Strength
0.280
-
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.
Score: 0.280
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.